These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Lovell MA; Ehmann WD; Butler SM; Markesbery WR Neurology; 1995 Aug; 45(8):1594-601. PubMed ID: 7644059 [TBL] [Abstract][Full Text] [Related]
9. Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical. Andorn AC; Britton RS; Bacon BR J Neurochem; 1996 Aug; 67(2):717-22. PubMed ID: 8764600 [TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Galbusera C; Facheris M; Magni F; Galimberti G; Sala G; Tremolada L; Isella V; Guerini FR; Appollonio I; Galli-Kienle M; Ferrarese C Curr Alzheimer Res; 2004 May; 1(2):103-9. PubMed ID: 15975074 [TBL] [Abstract][Full Text] [Related]
11. Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease. Götz ME; Wacker M; Luckhaus C; Wanek P; Tatschner T; Jellinger K; Leblhuber F; Ransmayr G; Riederer P; Eder E Neurosci Lett; 2002 May; 324(1):49-52. PubMed ID: 11983292 [TBL] [Abstract][Full Text] [Related]
12. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein. Singh M; Dang TN; Arseneault M; Ramassamy C J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576 [TBL] [Abstract][Full Text] [Related]
13. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966 [TBL] [Abstract][Full Text] [Related]
14. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues. Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719 [TBL] [Abstract][Full Text] [Related]
15. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. Kalaria RN; Andorn AC; Tabaton M; Whitehouse PJ; Harik SI; Unnerstall JR J Neurochem; 1989 Dec; 53(6):1772-81. PubMed ID: 2553864 [TBL] [Abstract][Full Text] [Related]
16. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease. Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694 [TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation and nitrite plus nitrate levels in brain tissue from patients with Alzheimer's disease. DiCiero Miranda M; de Bruin VM; Vale MR; Viana GS Gerontology; 2000; 46(4):179-84. PubMed ID: 10859455 [TBL] [Abstract][Full Text] [Related]
18. Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Hajimohammadreza I; Brammer M Neurosci Lett; 1990 May; 112(2-3):333-7. PubMed ID: 2359533 [TBL] [Abstract][Full Text] [Related]
19. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Marcus DL; Thomas C; Rodriguez C; Simberkoff K; Tsai JS; Strafaci JA; Freedman ML Exp Neurol; 1998 Mar; 150(1):40-4. PubMed ID: 9514828 [TBL] [Abstract][Full Text] [Related]
20. Kynurenine metabolism in Alzheimer's disease. Baran H; Jellinger K; Deecke L J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]